Keros Therapeutics shares owned by Rafferty Asset Management
Quarter-by-quarter ownership of Keros Therapeutics (KROS) shares owned by Rafferty Asset Management
from 13F filings
Historical chart of Rafferty Asset Management investment in Keros Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Keros Therapeutics held by Rafferty Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Keros Therapeutics by Rafferty Asset Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $697k | 44k | 15.82 |
| 2025-06-30 | $725k | 54k | 13.35 |
| 2025-03-31 | $564k | 55k | 10.19 |
| 2024-12-31 | $725k | 46k | 15.83 |
| 2024-09-30 | $2.4M | 41k | 58.07 |
| 2024-03-31 | $7.9M | 120k | 66.20 |
| 2023-09-30 | $1.9M | 58k | 31.88 |
| 2023-06-30 | $2.8M | 70k | 40.18 |
| 2023-03-31 | $2.7M | 63k | 42.70 |
| 2022-12-31 | $3.2M | 66k | 48.02 |
| 2022-09-30 | $2.2M | 57k | 37.63 |
| 2022-06-30 | $1.0M | 37k | 27.62 |
| 2022-03-31 | $1.9M | 34k | 54.39 |
| 2021-12-31 | $2.2M | 37k | 58.50 |
| 2021-09-30 | $963k | 24k | 39.55 |
| 2021-06-30 | $1.1M | 25k | 42.45 |
| 2021-03-31 | $2.1M | 34k | 61.56 |
| 2020-12-31 | $217k | 3.1k | 70.45 |